ES2056699T3 - Diaminoftalimidas substituidas y analogos. - Google Patents

Diaminoftalimidas substituidas y analogos.

Info

Publication number
ES2056699T3
ES2056699T3 ES92810385T ES92810385T ES2056699T3 ES 2056699 T3 ES2056699 T3 ES 2056699T3 ES 92810385 T ES92810385 T ES 92810385T ES 92810385 T ES92810385 T ES 92810385T ES 2056699 T3 ES2056699 T3 ES 2056699T3
Authority
ES
Spain
Prior art keywords
diaminoftalimides
analogs
substituted
proteinquinas
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92810385T
Other languages
English (en)
Spanish (es)
Inventor
Uwe Dr Trinks
Peter Dr Traxler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2056699T3 publication Critical patent/ES2056699T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Stringed Musical Instruments (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Electrophonic Musical Instruments (AREA)
  • Pyridine Compounds (AREA)
ES92810385T 1991-05-30 1992-05-21 Diaminoftalimidas substituidas y analogos. Expired - Lifetime ES2056699T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH160191 1991-05-30

Publications (1)

Publication Number Publication Date
ES2056699T3 true ES2056699T3 (es) 1994-10-01

Family

ID=4214234

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92810385T Expired - Lifetime ES2056699T3 (es) 1991-05-30 1992-05-21 Diaminoftalimidas substituidas y analogos.

Country Status (25)

Country Link
EP (1) EP0516588B1 (https=)
JP (1) JP2593273B2 (https=)
KR (1) KR920021508A (https=)
CN (1) CN1067052A (https=)
AT (1) ATE108437T1 (https=)
AU (1) AU653024B2 (https=)
CA (1) CA2069857A1 (https=)
CS (1) CS156792A3 (https=)
CY (1) CY1979A (https=)
DE (1) DE59200277D1 (https=)
DK (1) DK0516588T3 (https=)
ES (1) ES2056699T3 (https=)
FI (1) FI100530B (https=)
HK (1) HK214896A (https=)
HU (1) HUT66655A (https=)
IE (1) IE65772B1 (https=)
IL (1) IL102038A0 (https=)
MA (1) MA22540A1 (https=)
MX (1) MX9202544A (https=)
NO (1) NO178261C (https=)
NZ (1) NZ242941A (https=)
PL (1) PL170909B1 (https=)
RU (1) RU2095349C1 (https=)
TW (1) TW204341B (https=)
ZA (1) ZA923940B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5491144A (en) * 1991-05-30 1996-02-13 Ciba-Geigy Corporation Substituted diaminophthalimides and analogues
EP0600830A1 (de) * 1992-11-27 1994-06-08 Ciba-Geigy Ag Substituierte Derivate von Diaminophthalimid als Protein-Tyrosin-Kinase-Hemmer
EP0600831A1 (de) * 1992-11-27 1994-06-08 Ciba-Geigy Ag Phthalazinonderivate
PL176595B1 (pl) * 1993-06-25 1999-06-30 Main Camp Marketing Pty Ltd Środek leczniczy w postaci koncentratu z nasion selera i sposób otrzymywania środka leczniczego w postaci koncentratu z nasion selera
AU691815B2 (en) * 1993-06-25 1998-05-28 Main Camp Marketing Pty. Ltd. Therapeutic agent
GB9314893D0 (en) * 1993-07-19 1993-09-01 Zeneca Ltd Quinazoline derivatives
GB9325217D0 (en) * 1993-12-09 1994-02-09 Zeneca Ltd Pyrimidine derivatives
WO1995024190A2 (en) * 1994-03-07 1995-09-14 Sugen, Inc. Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
GB9600545D0 (en) 1996-01-11 1996-03-13 Ciba Geigy Ag Compositions
EP1661566A3 (en) * 1996-08-05 2008-04-16 Myriad Genetics, Inc. Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
CA2262900A1 (en) * 1996-08-05 1998-02-12 Molecumetics Ltd. Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
KR100840635B1 (ko) * 2001-11-30 2008-06-24 와코 쥰야꾸 고교 가부시키가이샤 비스이미드 화합물, 이것을 이용한 산 발생제 및 레지스트조성물 및 해당 조성물을 이용한 패턴 형성 방법
WO2005039564A1 (en) * 2003-10-02 2005-05-06 Vertex Pharmaceuticals Incorporated Phthalimide compounds useful as protein kinase inhibitors
US20060142591A1 (en) * 2004-10-25 2006-06-29 Susan Lindquist DAPH analogs and inhibition of protein aggregation
KR20080011199A (ko) 2005-04-19 2008-01-31 교와 핫꼬 고교 가부시끼가이샤 질소 함유 복소환 화합물
DE102009031058A1 (de) * 2009-06-30 2011-01-27 Clariant International Ltd. Kontinuierliches Verfahren zur Herstellung von Amiden aromatischer Carbonsäuren
JP5934559B2 (ja) * 2012-04-05 2016-06-15 国立大学法人京都工芸繊維大学 発光材料および有機el素子
CN105434432B (zh) * 2015-12-04 2018-11-13 中国科学院昆明植物研究所 N-羟基邻苯二甲酰亚胺类化合物在制备抗肿瘤药物中的应用
CA3226162A1 (en) 2021-07-09 2023-01-12 Plexium, Inc. Aryl compounds and pharmaceutical compositions that modulate ikzf2

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857947A (en) * 1972-08-14 1974-12-31 Stauffer Chemical Co Fungicidal active phthalimides
GB1581073A (en) * 1976-09-08 1980-12-10 Campbell Chain Co Locking assembly
JPS60161968A (ja) * 1984-01-31 1985-08-23 Sankyo Co Ltd フタ−ルイミド誘導体及び農業用殺菌剤

Also Published As

Publication number Publication date
NZ242941A (en) 1994-10-26
NO922133L (no) 1992-12-01
CN1067052A (zh) 1992-12-16
HUT66655A (en) 1994-12-28
IL102038A0 (en) 1992-12-30
FI100530B (fi) 1997-12-31
FI922459A0 (fi) 1992-05-27
TW204341B (https=) 1993-04-21
EP0516588B1 (de) 1994-07-13
ATE108437T1 (de) 1994-07-15
CY1979A (en) 1997-09-05
KR920021508A (ko) 1992-12-18
IE65772B1 (en) 1995-11-15
RU2095349C1 (ru) 1997-11-10
NO178261C (no) 1996-02-21
FI922459L (fi) 1992-12-01
MA22540A1 (fr) 1992-12-31
JP2593273B2 (ja) 1997-03-26
ZA923940B (en) 1993-11-15
DK0516588T3 (da) 1994-08-15
NO178261B (no) 1995-11-13
IE921770A1 (en) 1992-12-02
EP0516588A1 (de) 1992-12-02
HU9201789D0 (en) 1992-08-28
DE59200277D1 (de) 1994-08-18
AU1705392A (en) 1992-12-03
MX9202544A (es) 1992-11-01
JPH05163240A (ja) 1993-06-29
CS156792A3 (en) 1992-12-16
PL294701A1 (https=) 1993-02-08
AU653024B2 (en) 1994-09-15
CA2069857A1 (en) 1992-12-01
NO922133D0 (no) 1992-05-29
HK214896A (en) 1996-12-13
PL170909B1 (pl) 1997-02-28

Similar Documents

Publication Publication Date Title
ES2056699T3 (es) Diaminoftalimidas substituidas y analogos.
ES2192201T3 (es) Compuestos de piranona utiles para el tratamiento de infecciones retrovirales.
ES2174465T3 (es) Compuestos triazol y su utilizacion como ligandos de dopamina-d.
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
AR026938A1 (es) Combinaciones de productos activos fungicidas.
ES2096639T3 (es) Derivados de benzofurano, benzotiofeno, indol o indolizina, su procedimiento de preparacion, asi como las composiciones que los contienen.
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
PA8514401A1 (es) Nuevos derivados de piperazina
UY23835A1 (es) Procedimiento para la preparacion de compuesto de acilo
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
GT199900140A (es) Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos.
DK0381446T3 (da) Orale anti-svampepræparater
BR0110486A (pt) Antranilamidas e sua aplicação como medicamento
ES2084339T3 (es) Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central.
BR0215277A (pt) Dicetopiperazinas substituìdas como antagonistas da oxitocina
ES2118708T3 (es) Composiciones de piperidina y su preparacion y utilizacion.
ES2107035T3 (es) Derivados de 3-azabiciclo(3.2.0)heptano n-substituidos como neurolepticos etc..
ES2113358T3 (es) Composiciones antidiarreicas.
BR0008682A (pt) 3-amino-3-arilpropan-1-ol, processo para sua produção, seu uso e medicamento
ES2151168T3 (es) N-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
DE68903092D1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
ES2144154T3 (es) Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica.
AR001813A1 (es) Derivados de cromona procedimiento para prepararlos y las composiciones farmacéutica que los contienen
ES2114289T3 (es) Aminoalcanimidazoles y -triazoles acilados.
ES2127263T3 (es) Nuevos trien-derivados cromenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 516588

Country of ref document: ES